Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.38 |
| ▸ | PIM1 | P11309 | 2/20 | 0.38 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.38 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912082 | 0.95 | HSD11B1 (0.38) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL19912075 | 0.95 | HSD11B1 (0.38) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL19912074 | 0.95 | HSD11B1 (0.38) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL19912101 | 0.95 | HSD11B1 (0.38) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL19912088 | 0.95 | HSD11B1 (0.38) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL30423446 | 0.95 | HSD11B1 (0.38) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL19912097 | 0.95 | PSMB5 (0.39) | PSMB5HSD11B1PIM1PIM3PIM2 | |
| SCHEMBL19912109 | 0.92 | HSD11B1 (0.41) | HSD11B1PIM1PIM3PIM2EP300 | |
| SCHEMBL19912080 | 0.92 | HSD11B1 (0.41) | HSD11B1PIM1PIM3PIM2EP300 | |
| SCHEMBL19912086 | 0.91 | HSD11B1 (0.38) | HSD11B1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062087-A1 | Organic Compound, Organic Semiconductor Material, Organic Thin Film And Method For Producing The Same, Organic Semiconductor Composition, And Organic Semiconductor Device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| US-20180062087-A1 | Organic Compound, Organic Semiconductor Material, Organic Thin Film And Method For Producing The Same, Organic Semiconductor Composition, And Organic Semiconductor Device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062087-A1 | Organic Compound, Organic Semiconductor Material, Organic Thin Film And Method For Producing The Same, Organic Semiconductor Composition, And Organic Semiconductor Device | PROX1, NONO, PIEZO1 | PSMB5 3410/4885HSD11B1 130/4885PIM1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.